The other detail ; about PBT2 " •Evaluating non‐neurological indications for further development ". IMO one area could be: light chain amyloidosis in which Cherny at al ( italian group) demonstrated clear quick effect in an animal model.
- Forums
- ASX - By Stock
- ATH
- Ann: Investor presentation - Biotech Showcase
ATH
alterity therapeutics limited
Add to My Watchlist
6.67%
!
1.4¢

Ann: Investor presentation - Biotech Showcase, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $128.9M |
Open | High | Low | Value | Volume |
1.3¢ | 1.5¢ | 1.3¢ | $608.4K | 44.11M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 13043054 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 4937957 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 13043054 | 0.013 |
22 | 14957871 | 0.012 |
23 | 12663456 | 0.011 |
32 | 15388004 | 0.010 |
49 | 17854518 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 4937957 | 8 |
0.015 | 3624278 | 9 |
0.016 | 5009636 | 14 |
0.017 | 3742065 | 8 |
0.018 | 5132441 | 19 |
Last trade - 16.11pm 21/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |